As a Contract Research Organization in business since 1983, PMI has developed a reputation for quality science and quality service based on professional management and technical expertise. We are committed to helping customers succeed in their work, to the ethical treatment of our laboratory animals, and to furthering the commercial and humanitarian applications of the biotechnology and medical device industries.
Since its inception, PMI has established a reputation for excellent science, strong surgical and clinical skills, and customized, timely service. Built initially on word-of-mouth recommendations, our business has expanded rapidly based on our ability to respond quickly and strategically to the needs of a variety of clients, primarily medical device companies developing Class III medical devices.
Clients come to PMI for our fast, efficient and flexible approach to managing research projects. Experienced in working with both start-up and established companies, we understand the need to reach client milestones that are being monitored by the financial community. To that end, we are accustomed to expediting our review of novel protocols and accelerating our research schedule.
Applying its expertise in comparative medicine, PMI guides clients in adapting the product concept to an in vivo setting, advising on such variables as vessel size, anatomical locations and organ structure. Assistance in selecting a comparable animal model for a particular clinical indication is also provided.
PMI works hand in hand with biomedical engineers and physicians/surgeons to conduct in vivo pilot studies and fine-tune the adaptation of the prototype device, helping to optimize the product’s ease of use and clinical utility. Results can be produced quickly to help clients meet important business milestones.
IN THE NEWS
State-of-the-art suites at preclinical contract research organizations (CRO) provide a platform for residents to become familiar with the many devices […]
Pancreas and islet transplants are most often performed in people with Type 1 diabetes. Since the 1960s, pancreas transplants have […]